Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are tirzepatide (Zepbound) and semaglutide (Wegovy). Semaglutide was originally ...

Use of other glucose-lowering drugs, including metformin, rapidly declined. In January 2021, 13% of diabetes patients started GLP-1 medications, and by December 2023, that rate increased to 35%. The ...

Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022.

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

Fact checked by Nick Blackmer People using GLP-1 drugs to manage their weight may be more likely to develop acne, according to a recent report. In a retrospective study, researchers analyzed the ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

The Company reported positive topline data with co-administered melanocortin-4 receptor (MC4R) agonist bremelanotide plus glucagon like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) tirzepatide ...

Prescriptions for GLP-1 drugs rose even faster, climbing from 4% to 33% among severely obese adults with type 1 diabetes and 3% to 21% among severely obese children, results show.

A new clinical trial led by researchers at the University of North Carolina School of Medicine has revealed that the oral form of semaglutide (GLP-1) significantly reduces the risk of heart ...